Description
NVP-LDE225isaninhibitorofSmothatpreventshedgehog(Hh)signaling;itexhibitsanticancerchemotherapeuticandanti-metastaticactivities.NVP-LDE225iscurrentlyapprovedforthetreatmentofbasalcellcarcinomabutisalsoinclinicaltrialsasapotentialtreatmentforothercancers.Inrenalcellcarcinomacells,NVP-LDE225inhibitscellularproliferation,migration,andinvasion;inanimalmodels,itincreasessurvivalratesanddecreasestumorgrowth.NVP-LDE225alsoinhibitscellviABIlityinprostatecancercells.Inanimalmodelsofprostatecancer,thiscompoundinhibitstheepithelial-to-mesenchymaltransition(EMT),inducesapoptosis,decreasestheexpressionofBcl-2,Bcl-xl,XIAP,andsurvivin,andincreasestheexpressionofBaxandBak;italsoinhibitstumorgrowth.SmoantagoNISTssuchasNVP-LDE225alsocausealopecia,likelyduetoalterationinhairfollicleembryology.